Scientific Sessions 2024  /  Featured Science: Vascular Outcomes in the Spotlight  /  Discussant: ONCO PE Trial
Logo

American Heart Association

  112
  0

Final ID:

Discussant: ONCO PE Trial

  • Kadian, Daniella  ( Mount Sinai , New York City , New York , United States )
  • Casanegra, Ana  ( MAYO CLINIC , Rochester , Minnesota , United States )
  • Okwuosa, Tochi  ( RUSH UNIVERSITY , Chicago , Illinois , United States )
    • Author Disclosures:
    Daniella Kadian: DO have relevant financial relationships ; Consultant:Boston Scientific:Active (exists now) ; Speaker:Medscape:Active (exists now) ; Speaker:Women As One:Past (completed) ; Executive Role:Society for Vascular Medicine:Active (exists now) ; Executive Role:CLI Global Society:Active (exists now) ; Research Funding (PI or named investigator):Philips Healthcare:Past (completed) ; Speaker:Abbott Laboratories:Active (exists now) | Ana Casanegra: DO NOT have relevant financial relationships | Tochi Okwuosa: DO have relevant financial relationships ; Consultant:ANTEV:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Featured Science: Vascular Outcomes in the Spotlight

Monday, 11/18/2024 , 08:00AM - 09:15AM

Featured Science

More abstracts on this topic:
Bempedoic Acid and Limb Outcomes in Statin-Intolerant Patients with Peripheral Artery Disease: New insights from the Clear Outcomes Trial

Bonaca Marc, Canonico Mario Enrico, Li Na, Sasiela William, Nissen Steven, Lincoff Abraham, Nicholls Stephen

Evolution of Novel Therapies in Vascular Medicine

Creager Mark, Beckman Joshua

More abstracts from these authors:
Panelist 4

Kadian Daniella, Leleiko Rebecca

Genetics of FMD and SCAD: Where we are and where we need to go

Kovacic Jason, Saw Jacqueline, Ganesh Santhi, Kadian Daniella

You have to be authorized to contact abstract author. Please, Login
Not Available